Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 07-2001 | 04-2001 | 01-2001 | 12-2000 | 10-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -794 | 309 | -180 | -185 |
| Depreciation Amortization | N/A | 161 | 107 | 50 | 54 |
| Accounts receivable | N/A | 2,117 | -1,121 | N/A | 2,011 |
| Other Working Capital | N/A | 2,315 | -267 | 1,330 | 1,332 |
| Other Operating Activity | 0 | -1,959 | 1,219 | 30 | -1,977 |
| Operating Cash Flow | $N/A | $1,840 | $248 | $1,230 | $1,234 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -1,547 | -676 | N/A | -1,329 |
| PPE Investments | N/A | -26 | -19 | -10 | -19 |
| Purchase Of Investment | N/A | N/A | -175 | N/A | N/A |
| Other Investing Activity | 0 | -563 | 0 | -1,330 | 0 |
| Investing Cash Flow | $N/A | $-2,136 | $-870 | $-1,340 | $-1,348 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | N/A | -679 | -678 | N/A | -367 |
| Other Financing Activity | 0 | 0 | 0 | -360 | 0 |
| Financing Cash Flow | $N/A | $-679 | $-678 | $-360 | $-367 |
| Beginning Cash Position | N/A | 1,716 | 1,716 | 1,710 | 1,716 |
| End Cash Position | N/A | 741 | 417 | 1,230 | 1,236 |
| Net Cash Flow | $N/A | $-975 | $-1,299 | $-480 | $-481 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 1,840 | 248 | 1,230 | 1,234 |
| Capital Expenditure | N/A | -26 | -19 | N/A | -19 |
| Free Cash Flow | 0 | 1,814 | 230 | 1,230 | 1,215 |